Clinical Trial Update: Comparison of HES 130 in Balanced and in Unbalanced Solution [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing hydroxyethyl starch 130/0.4 in balanced versus unbalanced solutions for patients with decreased and nonspecific blood pressure disorde…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotension
• Shock

Drugs mentioned

• Hydroxyethyl starch 130/0.4 (balanced solution) (hydroxyethyl starch 130/0.4)

Snippet

Sponsor: B. Braun Melsungen AG | Conditions: Decreased and Nonspecific Blood Pressure Disorders and Shock | Phase 3 | Status: COMPLETED